Funders

It is challenging to fund research for rare and neglected disease drug discovery efforts. If you are interested in donating to our effort, please contact Michael Pollastri, or Lori Ferrins and we would be very happy to discuss ways in which you could help contribute to our program. We are very thankful to everyone who has already contributed to our program!

Our thanks to:

  • Northeastern University
  • The National Institutes of Health
  • The Tres Cantos Open Lab Foundation
  • Flatley Discovery

Compounds and Experiments

  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis
  • Rilas Technologies

Software and Hardware

  • OpenEye
  • ChemAxon
  • Collaborative Drug Discovery
  • Dotmatics
  • Waters, Inc.